Moreover, therapeutic drugs can also be delivered by certain nanomaterial delivery systems specifically to CAFs via FAP antibody-drug conjugate (e.g., FAP-targeted liposomes, anti-FAP-PE38 immunotoxin), resulting in potent anti-tumor effects [91,92]. Here, FAP is linked to neoplasm.